Flomerics Group PLC
23 October 2002
FOR IMMEDIATE RELEASE 23 October 2002
Flomerics Group plc
Statement in response to share price movement
The Board of Directors of Flomerics Group PLC notes the sharp move in the share
price earlier today.
The Board is therefore obliged to inform shareholders that it has recently
received an approach for the Company, which it is currently considering. The
Board would like to stress that discussions are at a very early stage and there
is no certainty that they will lead to a formal offer being made for the
Company.
A further announcement will be made in due course. In the meantime shareholders
are advised to take no action.
To the best of the knowledge and belief of the directors of Flomerics Group PLC
(who have taken reasonable care to ensure that such is the case) the information
contained herein for which they take responsibility is in accordance with the
facts and does not omit anything likely to affect the import of such
information.
- E N D S -
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.